VeriMomБезопасен ли polyvinylacetamide при беременности?
No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
Related ingredients
Frequently asked questions
- Безопасен ли polyvinylacetamide при беременности?
- No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- Безопасен ли polyvinylacetamide при грудном вскармливании?
- No data found showing transfer to breast milk or adverse effects during lactation for polyvinylacetamide. No authoritative safety assessment (CIR/SCCS/harmonised CLP) raising reproductive/lactation concerns was identified; therefore default scoring is 0. Potential concern would relate to residual monomer (N‑vinylacetamide) if present, but no data on levels or breast‑milk transfer were located. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- Безопасен ли polyvinylacetamide для кожи малыша?
- No evidence of developmental or infant‑specific hazard was found. For exposure (e) infants have a less mature skin barrier and higher surface‑area‑to‑weight ratio; polymers like poly(N‑vinylacetamide) are generally of low dermal absorption, so adult exposure is negligible (e=0) but infant exposure is increased to e=1 to reflect higher potential per‑weight exposure and possibility of measurable absorption if small amounts of low‑molecular‑weight species (residual monomer) are present. There is no infant‑specific toxicology showing increased hazard. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Poly%28N-vinylacetamide%29?utm_source=openai))
- Как VeriMom оценивает polyvinylacetamide?
- VeriMom оценивает polyvinylacetamide в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы polyvinylacetamide при беременности?
- См. наш список безопасных альтернатив polyvinylacetamide с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.